167 filings
Page 8 of 9
DEF 14A
p6s7ut a2v
15 May 19
Definitive proxy
5:15pm
10-Q
40ckwjuyiu26cbwjwqot
9 May 19
Quarterly report
4:33pm
8-K/A
mmf7oy
9 May 19
Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates
6:08am
8-K
ezf87h0l
8 May 19
Moderna Reports First Quarter 2019 Financial Results and Provides Business Updates
7:00am
8-K
te6h 5yhoklluee94r
7 May 19
Regulation FD Disclosure
6:50am
10-K/A
aehid9md0r xd
25 Apr 19
Annual report (amended)
5:15pm
S-8
2h59r3p6453
13 Mar 19
Registration of securities for employees
4:36pm
10-K
m0soq 663uh2bq
13 Mar 19
Annual report
4:22pm
8-K
vfqvf8wcn2r766
6 Mar 19
Moderna Reports 2018 Fourth Quarter and Full Year Financial Results
7:07am
8-K
j94iyjoyq
12 Feb 19
Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3
4:01pm
8-K
fom4cm
22 Jan 19
Other Events
7:30am
8-K
q08v2
18 Jan 19
DR. John Mendlein to Transition to an Advisory Role at Moderna and Join Flagship Pioneering As an Executive Partner
12:00am
8-K
0hh0h
8 Jan 19
Moderna Announces Recent Progress In Its Immuno-oncology and Rare Disease
8:30am
8-K
jbe9 2iu7cafp
14 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:24pm
S-8
2431ns4w6m 4n79mrm6
7 Dec 18
Registration of securities for employees
4:55pm
424B4
6rc39b
7 Dec 18
Prospectus supplement with pricing info
4:38pm
CERT
k88vjawu1gmmnxo
7 Dec 18
Certification of approval for exchange listing
8:56am
EFFECT
w4ibiq0r r0
7 Dec 18
Notice of effectiveness
12:15am
CT ORDER
9b00exeiwyzq3tmb h9
7 Dec 18
Confidential treatment order
12:00am
S-1MEF
dk54r01b m9c
6 Dec 18
Registration of additional securities for an S-1
7:46pm